Home > Kevin Sayer: Supporting Patients During COVID-19

Kevin Sayer: Supporting Patients During COVID-19

Published Online: June 24th 2020

It was a pleasure to speak to Kevin Sayer about the advances in continuous glucose monitoring systems and how these, combined with telemedicine, are helping to optimise support for patients remotely during COVID-19.


1. Please summarise the role of telehealth and the benefits of continuous glucose monitoring (CGM) during the COVID-19 pandemic (0:06)

2. What have we learned from this situation, and how do you think this will impact the future of type 1 diabetes management? (2:06)

3. Please summarise the data being presented by Dexcom at the ADA 2020 virtual annual meeting (3:15)

4. What can we look forward to in the future of Dexcom CGM? (4:24)


Speaker disclosure: Kevin Sayer is Executive Chairman, President & CEO, Dexcom.

Support: Interview and filming supported by Touch Medical Media. Commissioned in liaison with Allison+Partners.

Filmed in coverage of the ADA 2020 Virtual 80th Scientific Sessions.

Related Videos In COVID-19
  • Copied to clipboard!
    accredited arrow-downarrow_leftarrow-right-bluearrow-right-dark-bluearrow-right-greyarrow-right-orangearrow-right-whitearrow-right-blueavatarcalendarchevron-down crosscrossdownloademailexclaimationfeedbackfiltergraph-arrowinterviewslinkmenumore_dots padlock person play_buttonplay-colour-tmcplay-colourAsset 1podcastprinter scenerysearch share social_facebooksocial_googleplussocial_instagramsocial_linkedin_altsocial_linkedin_altsocial_pinterestlogo-twitter-glyph-32social_youtubeshape-star (1)tick-bluetick-orangetick-whiteticktimetranscriptup-arrowwebinar